Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
Science (New York, N.Y.)|January 6, 2018
Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cellsVeron Ramsuran, Vivek Naranbhai, Amir Horowitz, et al.Nature Immunology|July 2, 2024
High-dimensional single-cell analysis of human natural killer cell heterogeneityLucas Rebuffet, Janine E Melsen, Bertrand Escalière, et al.Blood Advances|November 26, 2019
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AMLBérengère Salomé, Alejandra Gomez-Cadena, Romain Loyon, et al.Cancer Discovery|July 3, 2024
Single-Cell View of Tumor Microenvironment Gradients in Pleural MesotheliomaBruno Giotti, Komal Dolasia, William Zhao, et al.European Urology|August 25, 2024
Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient SelectionRoger Li, Patrick J Hensley, Shilpa Gupta, et al.Immunity|June 8, 2020
Immunology of COVID-19: Current State of the ScienceNicolas Vabret, Graham J Britton, Conor Gruber, et al.Science Translational Medicine|October 5, 2018
Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individualsMathieu Uzzan, Minami Tokuyama, Adam K Rosenstein, et al.Nature Immunology|April 20, 2023
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancerMatthew D Park, Ivan Reyes-Torres, Jessica LeBerichel, et al.Nature Medicine|October 2, 2023
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trialMatthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, et al.Cancer Discovery|February 26, 2026
A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancerMichelle A Tran, Byuri Angela Cho, Sudeh Izadmehr, et al.Pageof 9